Also note that people who are allergic to shellfish have a 3% chance of being allergic to iodine which is about the same as patients with no known shellfish allergy. But check with your MD before trying below.
I had posted about this in the past: I am convinced that gargling Povidone Iodine (5%) (ie, Betadine diluted to 5%) and/or sticking cue tips soaked in Povidone Iodine or Betadine (and/or mixed with 70% alcohol) up your nose decreases viral loads of any virus and can prevent a full infection. I have also thought that trying to aerosolize Povidone Iodine (5%) may kill deeper infections in patients with COVID-19 pneumonia but this study has not been done yet.
-
1.Apply nasal and oral PVP-I every 2–3 h, up to 4×/day
-
a.Have suspected/confirmed SARS-CoV-2 infection
-
b.Are undergoing high-risk procedures (e.g. those involving nasal mucosal, oral, pharyngeal, and pulmonary secretions)
-
c.Are from COVID-19 hotspots
-
-
2.Apply nasal and oral PVP-I prior to and after patient contact (with repeated contact, apply every 2–3 h, up to 4×/day)
-
a.Are involved in care of patients with suspected/confirmed SARS-CoV-2 infection
-
b.Are involved in high-risk procedures of patients in COVID-19 hotspots
-
c.Lack adequate PPE (e.g. N95, PAPR)
-
-
3.Optional nasal and oral application of PVP-I every 2–3 h, up to 4×/day
-
a.High-risk procedures in asymptomatic patients
-
b.COVID-19 hotspots
With COVID, friends and colleagues have noted they do NOT have any weird feelings in their throat or nose until the headache and fever hits them hard. Still, if I got a headache & fever, I would still gargle Povidone Iodine (5%) and put it in my nose & massage my neck muscles & do the usual things I do to prevent the full attack and entry of the virus into my bloodstream (which is what elicits a fever).
A word of caution: What are the risks of Povidone Iodine:
1. Do not use if you are allergic to Iodine. If you are allergic to shellfish, there is about a 3% chance to will be allergic to iodine, so please check with your MD first before using povidone iodine/ Betadine.
3. If one were to use this extensively, there is a rare report of raising one’s blood iodine level which could be a risky but this is rare.
Consideration of povidone-iodine as a public health intervention for COVID-19: Utilization as “Personal Protective Equipment” for frontline providers exposed in high-risk head and neck and skull base oncology care
-
1.Apply nasal and oral PVP-I every 2–3 h, up to 4×/day
-
a.Have suspected/confirmed SARS-CoV-2 infection
-
b.Are undergoing high-risk procedures (e.g. those involving nasal mucosal, oral, pharyngeal, and pulmonary secretions)
-
c.Are from COVID-19 hotspots
-
-
2.Apply nasal and oral PVP-I prior to and after patient contact (with repeated contact, apply every 2–3 h, up to 4×/day)
-
a.Are involved in care of patients with suspected/confirmed SARS-CoV-2 infection
-
b.Are involved in high-risk procedures of patients in COVID-19 hotspots
-
c.Lack adequate PPE (e.g. N95, PAPR)
-
-
3.Optional nasal and oral application of PVP-I every 2–3 h, up to 4×/day
-
a.High-risk procedures in asymptomatic patients
-
b.COVID-19 hotspots
-
Declaration of Competing Interest
Article information
References
CLINICAL TRIAL:
https://clinicaltrials.gov/ct2/show/NCT04364802
I would add: intermittent fasting and low carb diet helps immune system. As do many suggestions on this previous blog post (like eat more tumeric, curry, Vitamin D, etc):
Finally there is a clinical trial on using Povidone Iodine/Betadine to prevent COVID’s viral load and infection. Why is not every university doing this study??
https://clinicaltrials.gov/ct2/show/NCT04364802
COVID-19: Povidone-Iodine Intranasal Prophylaxis in Front-line Healthcare Personnel and Inpatients (PIIPPI)
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. |
ClinicalTrials.gov Identifier: NCT04364802 |
Recruitment Status
First Posted
Last Update Posted
See
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
COVID-19SARS-CoV 2 | Drug: Povidone-Iodine Nasal Spray and Gargle | Phase 2 |
Study Type | Interventional (Clinical Trial) |
Estimated | 250 participants |
Allocation: | Non-Randomized |
Intervention Model: | Parallel Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Prevention |
Official Title: | Povidone-Iodine Intranasal for Prophylaxis in Front-line Health-care Personnel and Inpatients During the Sars-CoV-2 Pandemic |
Actual | April 29, 2020 |
Estimated | May 2021 |
Estimated | May 2021 |
Arm | Intervention/treatment |
---|---|
No Intervention: Healthcare Workers – Control
Front-line healthcare workers (FLCHW) who are negative for COVID will receive standard PPE and a pre- and post-study test for COVID-19.
|
|
Experimental: Healthcare Workers – PVP-I
Front-line healthcare workers (FLCHW) who are negative for COVID-19 will receive standard PPE and a pre- and post-study test for COVID-19. Additionally, they will receive PVP-I spray and gargle.
|
Drug: Povidone-Iodine Nasal Spray and Gargle
Healthcare workers will receive standard PPE and a pre- and post-study nasal swab COVID19 test. Additionally, they will receive povidone-iodine nasal spray and gargle (10% diluted 1:30) to use at the beginning of their shift, in the middle, and at the end of their shift.
|
No Intervention: Inpatients – Control
Inpatients who have a 7+ day hospitalization or who are set to undergo a significant surgical procedure will receive standard care and a pre- and post-study COVID-19 test.
|
|
Experimental: Inpatients – PVP-I
Inpatients who have a 7+ day hospitalization or who are set to undergo a significant surgical procedure will receive standard care and a pre- and post-study COVID-19 test. Additionally, they will receive PVP-I gargle and nasal sprays that will be applied shortly after admission or perioperatively.
|
Drug: Povidone-Iodine Nasal Spray and Gargle
Patients will receive standard of care treatment and a pre- and post-study nasal spray COVID19 test. Additionally, they will receive povidone-iodine nasal spray and gargle shortly after admission or preoperatively.
|
- Percent of healthcare workers testing positive for COVID-19. [ Time Frame: 3 weeks ]
Percent of healthcare workers that become positive for COVID-19 during the study.
- Percent of patients testing positive for COVID-9. [ Time Frame: 2 weeks ]
Percent of patients that become positive for COVID-19 during the study.
- PVP-I Ease of Use [ Time Frame: 3 weeks ]
Patients will rate the ease of use for PVP-I treatment on a scale from 1-5 after the initial use. Lower scores indicate increased ease of use (1=”easy”) while higher scores indicate increased difficulty (5=”impossible”).
- PVP-I Comfort [ Time Frame: 3 weeks ]
Patients will rate the comfort of PVP-I treatment on a scale from 1-5 after the initial use. Lower scores indicate increased comfort (1=”not so bad”) while higher scores indicate discomfort (5=”worst pain of my life”).
- Adherence to treatment protocol [ Time Frame: 3 weeks ]
Participants will fill out a daily questionnaire assessing treatment frequency. Adherence will be calculated as the percent of correct dosing.
Ages Eligible for Study: | 18 Years to 99 Years (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | Yes |
- healthcare worker OR
- patient with expected hospital stay of 7+ days OR
- patient admitted for major surgery
- COVID19 negative by nasal swab test
- asymptomatic for COVID19
- able to consent
- positive for COVID19 by nasal swab
- symptomatic for COVID19
- unable to consent
- Letter
- Published:
Povidone iodine
References
- 1.
To K K-W, Tsang OT-Y, Chik-Yan Yip C
- 2.
Kirk-Bailey J, Combes J, Sunkaraneni S, Challacombe S. The use of Povidone Iodine nasal spray and mouthwash during the current COVID-19 pandemic for the reduction of cross infection and protection of healthcare workers. (submitted) Last revised 16 April 2020. Available at:
- 3.
Eggers M, Koburger-Janssen T, Eickmann M, Zorn J. In vitro bactericidal and virucidal efficacy of Povidone-Iodine gargle/mouthwash against respiratory and oral tract pathogens.
- 4.
Kariwa H, Fujii N, Takashima I. Inactivation of SARS coronavirus by means of povidone-iodine, physical conditions and chemical reagents.
- 5.
American Dental Association (ADA) Interim Guidance for Minimizing Risk of COVID-19 Transmission 2020. Available at:
Author information
Affiliations
Cardiovascular Collapse Following Povidone-Iodine Wash
Free article
Abstract
In Vitro Bactericidal and Virucidal Efficacy of Povidone-Iodine Gargle/Mouthwash Against Respiratory and Oral Tract Pathogens
Gargling for Coronavirus? What Science Can Tell Us
There is no firm proof that gargling prevents respiratory infections caused by coronavirus — or any virus or bacteria. But there’s also little downside.
By Neal Naito, M.D.
-
Published March 29, 2020Updated April 14, 2020
As Americans search for ways to fight the spread of the coronavirus, one popular topic that has generated interest on the internet is gargling. What’s behind the gargling claim, and is there any medical proof that gargling may help to fight coronavirus or other respiratory infections?
To date, as with many things in medicine, there has been no “gold standard” large-scale randomized controlled trial to confirm the effectiveness of gargling with salt water, vinegar or any other oral solutions to prevent upper and lower respiratory infections caused by coronavirus or any other virus or bacteria. Smaller studies have shown that mouthwash and various other liquids commonly used to gargle can kill microbes, but whether gargling actually prevents or treats disease has not been proven in rigorous trials.
Still, gargling is a common hygiene measure in many countries. In East Asia, particularly in Japan, gargling is strongly encouraged by the national government, along with other practices like hand-washing, wearing face masks and social distancing, as a matter of routine hygiene during the regular cold and flu season. (Not everyone, though, can gargle effectively, including some people with neck pain, stroke or dementia, as well as children generally under the age of 8.) Most of the early studies suggesting that gargling may help to prevent and treat upper and lower respiratory infections, not surprisingly, come from Japan.
The most intriguing findings center on the use of an over-the-counter povidone-iodine oral gargle solution, which has been commonly used for decades by people in Japan and elsewhere to treat a sore throat. In a small Japanese experimental study from 2002, 23 patients with chronic respiratory disease gargled four or more times a day with a povidone-iodine solution. Researchers found that, compared to the number of acute respiratory infections before the group started gargling, regular gargling for several months to two years with the povidone-iodine solution led to an approximate 50 percent reduction in the incidence of acute respiratory infections. Gargling with the solution led to a reduction in infections caused by some fairly virulent bacteria, among them Pseudomonas, Staph (including MRSA) and Haemophilus.
Laboratory studies have also suggested potential benefits from gargling, though a major limitation of these test-tube studies is that what works in the lab may not translate to health benefits for patients. A recent German lab study sponsored by a manufacturer of povidone-iodine sore throat gargle solution, for example, reported that the solution was shown to eliminate over 99 percent of the coronaviruses that cause SARS and MERS (very close cousins to the current Covid-19). An earlier Japanese lab study revealed that povidone-iodine products outperformed other common antiseptics such as chlorhexidine gluconate and benzalkonium chloride in inactivating many other common problematic viruses, such as coxsackie, rhinovirus, adenovirus, rotavirus, influenza, to name a few. Clinical trials in people would be needed to determine the clinical relevance for patients.
In the United States, povidone-iodine solutions are sold as skin disinfectants, which contain ingredients that can cause serious harm if ingested; preparations that are suitable for gargling are not generally available in this country. It’s critical that people not gargle with skin disinfectant solutions, including those that contain povidone-iodine. In Canada, a povidone-iodine gargle solution is sold under the brand name Betadine. Some people are allergic to iodine, however, and iodine can cause problems in patients with thyroid problems.
There is less evidence for the potential antimicrobial benefits of other gargle solutions. Listerine antiseptic, for example, has been shown to have antiviral activity in laboratory test-tube studies against some viruses that had been exposed for at least 30 seconds, though studies have not looked at coronavirus.
A recent intriguing clinical study from England involving 66 patients suggested that using a homemade hypertonic saline solution for nasal irrigation and gargling significantly reduced the incidence of flu and colds. (Some common colds are caused by coronaviruses, though they are far less dangerous than the strain of coronavirus that is currently circulating.) While nasal irrigation requires a sterile preparation, gargling does not. The gargling solution in the study involved a heaping teaspoon of salt in a cup of water to make an approximate 3 percent saline solution, gargled up to six times a day. A follow-up lab study by the same group of investigators discovered a potential mechanism of action of the saline solution, whereby throat cells took up extra chlorine from the saline solution to produce a compound that has known antiviral properties.
Other small studies have suggested potential beneficial anti-viral activity of gargling with green tea or solutions containing catechins, active ingredients of green tea, or with apple cider vinegar. These studies, however, were done in the laboratory, so have unknown clinical relevance for patients, and none looked at coronavirus specifically. One study even suggested that gargling with tap water alone may even be helpful in reducing the incidence of upper respiratory infections in a healthy population, although a later study did not confirm this finding.
Over all, looking at gargling from a risk-benefit ratio perspective, there seems to be little downside to frequent gargling. It’s a low-cost intervention, and may help to treat a sore throat. Whether gargling will actually fight off colds or flu, however, let alone the more serious coronavirus that is currently circulating, remains indeterminate as the current evidence base is limited.
Neal Naito, M.D., M.P.H., a former director of public health for the U.S. Navy, is a private practice health care consultant living in Maryland.